𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal perfusion rate determined for in situ intestinal absorption studies in rats

✍ Scribed by Paul M. Savina; A. E. Staubus; T. S. Gaginella; D. F. Smith


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
651 KB
Volume
70
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Etretinate absorption in the in situ per
✍ Cheryl L. Zimmerman; Kenneth E. Johnson πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 431 KB πŸ‘ 2 views

The absorption characteristics of etretinate were examined in the Sprague-Dawley rat with the use of the in situ intestinal lumen perfusion model. Intestinal segments of 15-50cm were cannulated and perfused with etretinate solutions of 178-1405 pgm1-I in a single-pass manner at flow rates of 0.154.9

In vivo Study of the Absorption of Seawe
✍ D. Bougle; M. Boudey; P. Arhan; F. Bureau; D. Neuville; M. Drosdowsky πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 2 views

The intestinal absorption of seaweed minerals (Ca, Zn, Fe) was compared with their inorganic salts, in YI'YO, using a perfused intestinal loop in the rat. A similar uptake of Ca from both sources was observed (19.1k21.0 vs 9.9k14.7 pmoVcm/min, NS), (meankl SD), as for Zn (38.8i26.5 vs 47.4k35.0 p,mo

The intestinal absorption of a prodrug o
✍ AndrΓ© H. Eriksson; Manthena V.S. Varma; Everett J. Perkins; Cheryl L. Zimmerman πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 136 KB

LY354740 is a potent mGlu2/3 agonist with a limited oral bioavailability. Its alanyl prodrug, LY544344, showed high affinity to the intestinal peptide transporter PEPT1, and improved the oral bioavailability of LY354740 in various animal models. The aim of the present study was to investigate the me

A statistical method for the determinati
✍ Steven C. Sutton; M. T. S. Rinaldi; J. M. McCarthy; K. E. Vukovinsky πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 1 views

The guide "Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Dosage Forms Containing Certain Active Moieties/Active Ingredients Based on a Biopharmaceutical Classification System" (Rockville, MD: CDER, 2000) outlined non-in vivo tests of permeability that may s